TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›CLMT›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Calumet, Inc. /DE (CLMT) financials

Income statement

Calumet, Inc. /DE (CLMT) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$4.69B$4.18B$4.19B$4.14B
Revenue growth—-10.8%0.2%-1.2%
Gross profit$352M$452M$231M$246M
Gross margin7.5%10.8%5.5%5.9%
Operating income$132M$267M$8.10M$109M
Operating margin2.8%6.4%0.2%2.6%
Net income-$173M$48.1M-$222M-$33.8M
Net margin-3.7%1.2%-5.3%-0.8%
EPS (diluted)——-$2.67-$0.39

Cash flow

Calumet, Inc. /DE (CLMT) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow$101M-$14.9M-$46.4M$109M
Capital expenditures$536M$272M$76.7M$52.3M
Free cash flow-$436M-$287M-$123M$56.6M

Balance sheet

Calumet, Inc. /DE (CLMT) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$35.2M$7.90M$38.1M$125M
Total assets—$2.75B$2.76B$2.69B
Total liabilities—$3.00B$3.22B$3.18B
Long-term debt—$1.83B$2.06B$2.08B
Shareholders' equity-$533M-$490M-$712M-$733M
Retained earnings——-$1.54B-$1.57B
Shares (wtd avg diluted)79.3M80.1M83.1M86.8M

Every figure is extracted from Calumet, Inc. /DE’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Calumet, Inc. /DE's annual revenue?
Calumet, Inc. /DE (CLMT) reported $4.14B of revenue for fiscal year 2025 — down 1.2% from $4.19B in FY2024, per its annual report filed with the SEC.
Is Calumet, Inc. /DE profitable?
Not in FY2025 — CLMT reported a net loss of $33.8M, per SEC filings.
What is Calumet, Inc. /DE's free cash flow?
$56.6M in FY2025 (operating cash flow $109M minus $52.3M of capital expenditures), from the SEC cash-flow statement.
Does CLMT pay a dividend?
Calumet, Inc. /DE reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full CLMT analysis — verdict, score & filings →Is CLMT a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.